Home > Healthcare > Medical Devices > Diagnostic Devices > Kidney Function Tests Market
Kidney Function Tests Market Size
Kidney Function Tests Market was valued at around USD 855 million in 2022 and is expected to boost the business growth at 6.2% CAGR over the forecast period.
Major factors driving the market growth includes the rising prevalence of chronic kidney diseases, increased demand for highly precise kidney function test, technological advancements in rapid diagnostic tests, etc. The chronic kidney disease (CKD) is considered as one of the major public health concerns globally. The overall estimated prevalence of CKD is approximately 13.4% worldwide. CKD directly affects & contributes to the global disease burden in terms of morbidity and mortality worldwide.
| Report Attributes | Details |
|---|---|
| Base Year: | 2022 |
| Market Size in 2022: | USD 855 Million |
| Forecast Period: | 2023 to 2032 |
| Forecast Period 2023 to 2032 CAGR: | 6.2% |
| 2032 Value Projection: | USD 1.5 billion |
| Historical Data for: | 2018 to 2022 |
| No. of Pages: | 210 |
| Tables, Charts & Figures: | 509 |
| Segments covered: | Product Type, Test Type, End-use, and Region |
| Growth Drivers: |
|
| Pitfalls & Challenges: |
|
As per the U.S. Renal Data System 2020 Annual Data Report statistics, the Medicare spending concerning with CKD External link beneficiaries aged 66 and above exceeded USD 70 billion in 2018, accounting for around 23.8% of Medicare spending in this age group. The rising contribution of such conditions that contribute to the overall disease burden is set to prove beneficial for the market. Thus, the rise in the prevalence of CKD conditions and increasing disease burden is set to fuel the kidney function tests market growth in the foreseeable future.
Kidney function tests are quick urine and blood tests that aid in locating and assessing any issues with the kidneys. One of the initial tests that can be performed to determine the health of the kidneys is urine testing, which is more prevalent. However, lack of awareness regarding kidney function tests may inhibit the marker revenue.
Covid-19 Impact
The emergence of COVID-19 is an unprecedented public health concern that has impacted the kidney function tests industry growth positively during the pandemic. Various restrictions were imposed across several countries globally to avoid the spread of the virus. The COVID-19 outbreak has affected the overall healthcare industry. COVID-19 patients were highly prone to kidney related problems including detection of high levels of protein or blood in patient urine among other abnormalities.
In some cases, adults suffering from COVID-19 developed an acute kidney injury that resulted in kidney function failure. Further, according to some research studies, around 40% of the COVID-19 patients showed symptoms of abnormal kidney function. Hence, to avoid developing the risk of chronic kidney disorders, the healthcare professionals recommended the COVID-19 patients to get tested on regular basis for kidney function tests. Thus, the COVID-19 pandemic has had a slightly positive impact on kidney function tests industry.
Kidney Function Tests Market Trends
The increasing prevalence of chronic kidney disorders and acute kidney injuries is anticipated to drive the global market statistics in the coming years. The BMC Nephrology Journal, in 2018, estimated that the number of people suffering with kidney disease exceeds 850 million with approximately 843.6 million accounting for chronic kidney disease (CKD). Also, a two-fold surge in the mortalities from chronic kidney diseases over the last 3 decades accounted for significant disease burden.
The surge in the prevalence & mortality associated with chronic kidney diseases is amongst the key variables that is set to prove beneficial for the market. Kidney function test results are observed as highly significant in evaluating kidneys functionality. As a result, the rise in the prevalence & mortality rates of chronic kidney diseases is projected to fuel the kidney function test, thereby driving the market growth.
Kidney Function Tests Market Analysis
Based on product type, the market is bifurcated into dipsticks, disposables, and reagents. The dipsticks segment accounted for major revenue share of over 58% in 2022 in the kidney function tests market. The kidney function tests employing dipstick technology are highly recommended by physicians for mobile and accurate COVID-19 testing. These tests are routinely used among patients with conditions that increase the risk of kidney disease comprising diabetes & hypertension.
Based on test type, the kidney function tests market is segmented into blood tests and urine tests. The urine tests segment held the majority share and was valued at around USD 529 million in 2022. High revenue share is primarily attributed to the fact that urine tests are the most frequently used procedures for kidney function tests. They are used to detect if the kidneys are leaking any bodily substances such as protein through urine, which can be a major symptom of abnormal kidney function. Urine tests are also used to detect if a person is suffering from pre-renal, renal, or post-renal uraemia.
Further, ease in sample collection in comparison to blood tests, minimal risk of infection, and surging use of dipsticks will further boost the segmental revenues. Hence, all the above-mentioned variables are anticipated to propel the industry growth over the forecast period.
Based on end-use, the market is segmented into hospitals, diagnostic laboratories and others. The diagnostic laboratories segment held a significant share in 2022 and is anticipated to witness fastest growth with a CAGR of 6.6% throughout the forecast period. Rise in target population of people suffering from different kidney disorders, increasing prevalence of chronic kidney diseases, surging geriatric population among others are prime factors responsible for increasing patient footfall in diagnostic laboratories.
Glomerular filtration rate (GFR), Creatinine clearance among others are the key renal/kidney function tests that are being carried out in diagnostic laboratories. Further, availability of well-trained healthcare personnels, better infrastructure and advanced equipment, and consistent rise in number of diagnostic laboratories are anticipated to further fuel the segmental growth. Hence, owing to afore-mentioned pointers, the market is projected to record robust growth over the forecast period.
North America held the dominating revenue share in the global kidney function tests market and is expected to reach over USD 652 million by 2032. The growing patient population for acute kidney injuries, rising prevalence of urinary disorders and related co-morbidities along with increasing awareness levels for proper diagnostic procedures in the region is projected to fuel the market growth.
Kidney Function Tests Market Share
Few of the leading players operating in the kidney function tests market include
- F. Hoffmann-La Roche Ltd.
- Abbott Laboratories
- Danaher Corporation
- Bio-Rad Laboratories, Inc.
- 77 Elektronika Kft
- Quest Diagnostics
- Nova Biomedical
The market is fragmented in nature, with major organizations, local small players, and start-ups joining the industry competition. The key industry players are involved in strategic developments including mergers and acquisition, collaboration, and product launches to further improve their market positioning and revenue generating capabilities.
Kidney Function Tests Industry in News:
- In August 2022, Bloom Diagnostics, a Swiss medical technology company has launched its latest product: The Bloom Kidney Test. The test is specifically designed for adult patients above 18 years for quantitative measurement of cystatin C in whole blood. This product launch will improve their product offering and help them to be at par with the rival companies.
- In March 2022, Nova Biomedical launched its new screening tool Nova Max Pro Creatinine/eGFR Meter System for improving kidney care. The tool is used to measure two key indicators of kidney health such as blood creatinine level and calculate eGFR. Such novel product launch will allow the company to increase its presence in the renal function testing industry.
Kidney function tests market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032, for the following segments:
Click here to Buy Section of this Report
By Product Type, 2018 - 2032 (USD Million & Units)
- Dipsticks
- Reagents
- Disposables
By Test Type, 2018 - 2032 (USD Million)
- Urine Tests
- Urine Protein Tests
- Microalbumin Tests
- Creatinine Clearance Tests
- Blood Tests
- Serum Creatinine Tests
- Blood Urea Nitrogen Tests
- Glomerular Filtration Rate Tests
By End-use, 2018 - 2032 (USD Million)
- Hospitals
- Diagnostic Laboratories
- Others
The above information is provided for the following regions and countries:
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Spain
- Italy
- Poland
- Sweden
- Netherlands
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Indonesia
- Philippines
- Vietnam
- Latin America
- Brazil
- Mexico
- Argentina
- Columbia
- Peru
- Chile
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Turkey
- Israel
- Iran
Frequently Asked Questions (FAQ) :